Posts in Industry News
Lentitek secures £250k seed investment to commercialize enabling biotechnologies for advanced cancer treatments and gene therapies

Edinburgh based Lentitek Ltd (Lentitek), a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment.  This investment will be deployed to further advance its technology and commence initial commercial trials. 

Read More
Firefinch Software announces partnership with i4 Product Design

Firefinch Software and i4 Product Design (i4PD) have announced that they have entered into a strategic partnership that will bring together the market leading software expertise of Firefinch Software with the hardware product design and development experience of i4PD, creating a one stop shop for start-ups and new businesses looking to bring their ideas quickly to market.

Read More
Roslin Tech closes Series A funding round

Roslin Tech, an Edinburgh-based food & ag tech company, is pleased to announce the closing of its series A capital raise led by Novo Holdings, a leading international life sciences investor. This £11 million funding round will fuel the company’s next wave of growth in its mission to become the leading provider of animal cell lines to the emerging cultivated meat sector.

Read More
Biorenewables Development Centre is involved in two new projects aimed at decarbonising the UK transport sector.

The Biorenewables Development Centre (BDC) is part of two new Hydrogen BECCS (Bioenergy with Carbon Capture and Storage) Innovation Programme projects which has been funded by the Net Zero Innovation Portfolio (NZIP) that have been awarded by the Department for Business, Energy and Industrial Strategy (BEIS).

Read More
Absolute Antibody Increases Automation Capabilities and Expands Production Facility to Support Continued Growth of its Recombinant Antibody Technology

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced the near doubling of its manufacturing facility in northeast England. The increased laboratory space includes a major investment in new automation for Next Generation Sequencing (NGS), expression and purification (HPLC) to enhance recombinant antibody production workflows.

Read More